Daniel Floyd Email & Phone Number

Hercules, CA, US

Global, Global, OO

Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. - Formerly GE Healthcare Life Sciences, Cytiva was formed as a result of the divestiture of the GE Healthcare Biopharma business to Danaher Corporation

Chicago, US

Part of a global innovation team focused on external technology scouting and development of future commercial opportunities

Singapore, Singapore, SG

• Esco Ventures is the corporate venture arm of Esco Micro Pte Ltd, a family owned producer of laboratory, hospital and pharmaceutical equipment. Esco Ventures invests in innovative life science and biotechnology.
• Closed Series A investment in a Boston based diagnostics startup and represented the fund as an observer in board of director meetings
• Developed a prototype for a novel immunoassay tool designed for high sensitivity, customizability, and low cost: a key unmet need in the academic and medtech R&D markets.
• Established network of investors and entrepreneurs that facilitated access to deal flow in the US and Europe

Singapore, SG

• The National University of Singapore (NUS) is one of the premier research universities in Asia and is home to several world class research centers including the Centre for BioImaging Sciences led by Prof. Paul.
• Produced detailed characterization of emission spectra of fluorescent proteins and organic dyes, establishing the basis for application of CL in biological imaging
• Developed method to enhance CL emission resulting in first ever demonstration of stimulated emission from electron excited chromophores

Cambridge, Massachusetts, US

• Carried out postdoctoral research with Professor Marko Lončar in the Laboratory for Nanoscale Optics within the School of Engineering of and Applied Sciences.Projects:Label-free biosensing with photonic crystal nano.
• First demonstration of optical detection of single proteins using a CMOS compatible sensor design
• Demonstrated feasibility of large scale manufacture of luminescent nanodiamonds with defined size and NV content, which is critical for many advanced applications.

Boston, MA, US

• Doctoral dissertation research was carried out at the laboratories of Profs. Antoine van Oijen (currently at Wollongong University, Australia) and Stephen Harrison.Study of viral membrane fusion through single particle.
• Organized collaboration and initiated a novel research program that continues to impact the research in both advisors’ laboratories.
• Developed a platform including hardware and analysis/modeling software which allowed the study of viruses at early stages in the infection cycle.
• Uncovered strong evidence that influenza hemagglutinin functions as a multi-protein complex, which led to a new push towards a universal vaccine.

Cambridge, Massachusetts, US

• Biophysics 204: Structural Biology from Molecules to Cells
• Composed and delivered lectures, tutored students on problem sets.

Eastern Taipei, TW

• Advisor: Gu-Gang ChangProject: Enzymology of malic enzyme.
• Performed site-directed mutagenesis studies to study enzyme dimer interfaces.
• Measured protein dimerization by analytical ultracentrifugation.

New York, NY, US

• Advisor: Liang TongThesis: Structural biology and enzymology of malic enzyme
• Produced and purified recombinant proteins for crystallization.
• Crystallized proteins, acquired x-ray diffraction data and assisted in structure determination.
• Acquired enzyme kinetics data, characterized inhibition mechanism.

New York, NY, US

• Led weekly recitation sections to supplement lectures, designed and graded exams

Phd, Biochemistry

Ab, Biochemistry